Product Description: Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases[1].
Applications: Metabolism-sugar/lipid metabolism
Formula: N/A
References: [1]Rossi M, et al. Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice. Am J Cardiovasc Drugs. 2022 Mar;22(2):141-155.
CAS Number: 2250073-78-8
Molecular Weight: N/A
Research Area: Metabolic Disease; Cardiovascular Disease